Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 20 July 2017 | By Michael Mezher
The US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) this week detailed changes to its process for handling requests for the agency to recognize new voluntary consensus standards for medical devices, as required by the 21st Century Cures Act.
Medical device makers often rely on consensus standards in the development and testing of their products, and FDA allows device makers to submit a declaration of conformity to show that their device is in line with a specific standard.
FDA currently recognizes more than 1,200 consensus standards for medical devices developed by standards bodies such as the International Organization for Standardization (ISO), American National Standards Institute (ANSI) and the International Electrotechnical Commission (IEC).
Under the Cures act, FDA is directed to respond to such requests in writing within 60 days of receiving the request. The agency is also required to publish its rationale for recognizing all or part of the standard, or for not accepting it, in the Federal Register.
For those looking to get a new standard recognized by the agency, FDA asks that they send a request including the name of the standard, its reference number and a list of devices that the standard should routinely apply to for declarations of conformity.
To back up the request, FDA says they should include a scientific, technical and regulatory rationale for the standard, as well as "a brief identification of the testing or performance or other characteristics of the device(s) or process(es) that would be addressed by a declaration of conformity."
In light of the new policy, FDA says it is also considering updates to three of its existing guidance documents related to consensus standards, including Recognition and Use of Consensus Standards, CDRH Standard Operating Procedures for the Identification and Evaluation of Candidate Consensus Standards for Recognition, and Frequently Asked Questions on Recognition of Consensus Standards.
FDA
Tags: Consensus Standards, 21st Century Cures Act
Regulatory Focus newsletters
All the biggest regulatory news and happenings.